| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Jasper Therapeutics, Inc. | Director | Stock Option (right to buy) | 7.5K | Jul 3, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| JSPR | Jasper Therapeutics, Inc. | Jul 3, 2025 | 1 | $0 | 4 | Jul 3, 2025 | Director |
| JSPR | Jasper Therapeutics, Inc. | Jun 6, 2024 | 1 | $0 | 4 | Jun 10, 2024 | Director |
| JSPR | Jasper Therapeutics, Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director |
| JSPR | Jasper Therapeutics, Inc. | Feb 16, 2023 | 0 | $0 | 3/A | Feb 27, 2023 | Director |
| JSPR | Jasper Therapeutics, Inc. | Feb 16, 2023 | 1 | $0 | 4 | Feb 17, 2023 | Director |